The point-of-care opioid testing market size is projected to be worth USD 450.9 million in 2023. The market is likely to surpass USD 725.1 million by 2033 at a CAGR of 4.9% during the forecast period.
The market for point-of-care opioid testing has been experiencing substantial growth and is expected to continue expanding. The increasing prevalence of opioid abuse, the opioid crisis, and the need for immediate and accurate detection are the key drivers of this market growth.
The market size is influenced by factors such as regional variations in opioid abuse rates, regulatory policies, and healthcare infrastructure.
Point-of-care opioid testing find applications in diverse settings, including emergency departments, addiction treatment centers, law enforcement agencies, workplace drug testing programs, and community outreach programs.
The ability to conduct immediate on-site testing without the need for specialized laboratory equipment makes these kits highly valuable in scenarios where rapid decision-making is critical.
Other Drivers Propelling the Demand for Point-of-Care Opioid Testing Market include:
Challenges for Companies /Manufacturers in the Point-of-Care Opioid Testing Market:
Opportunities in the Point-of-Care Opioid Testing Market Industry:
Latest Trends in the Point-of-Care Opioid Testing Market:
| Attributes | Details |
|---|---|
| Point-of-Care Opioid Testing Market Size (2023) | USD 450.9 million |
| Point-of-Care Opioid Testing Market Projected Size (2033) | USD 725.1 million |
| Value CAGR (2023 to 2033) | 4.9% |
Exclusive Offer: 30% Off on Regional Reports
Get a free sample report and customize your regions for a 30% discount on your regional report!
From 2017 to 2022, the global point-of-care opioid testing market experienced a CAGR of 3.9%, reaching a market size of USD 450.9 million in 2023.
From 2017 to 2022, the global point-of-care opioid testing industry witnessed significant growth as advancements in testing technologies have significantly contributed to the historic growth of the market.
The development of point-of-care testing with improved accuracy, sensitivity, and speed has facilitated rapid screening and early detection of opioid use. These technological advancements have enhanced the convenience and accessibility of testing, leading to increased adoption and market growth.
Future Forecast for Point-of-Care Opioid Testing Market Industry:
Looking ahead, the global point-of-care opioid testing market industry is expected to rise at a CAGR of 4.9% from 2023 to 2033. During the forecast period, the market size is expected to reach USD 725.1 million by 2033.
The point-of-care opioid testing industry is expected to continue its growth trajectory from 2023 to 2033, driven by increasing emphasis on patient-centered care and remote monitoring, there will be a growing demand for convenient and accessible testing options that can be performed in the comfort of one's home.
Home-based testing kits and connected devices will empower individuals to monitor their opioid use, promote self-management, and facilitate remote consultations with healthcare providers.
| Country | The United States |
|---|---|
| Market Size (USD million) by End of Forecast Period (2033) | USD 227.4 million |
| CAGR % 2023 to End of Forecast (2033) | 4.2% |
The point-of-care opioid testing industry in the United States is expected to reach a market size of USD 227.4 million by 2033, expanding at a CAGR of 4.2%. The opioid crisis remains a significant driver of the point-of-care opioid testing market in the United States.
The increasing prevalence of opioid misuse and addiction has prompted healthcare providers, policymakers, and stakeholders to prioritize interventions and strategies to combat the crisis. Point-of-care opioid testing plays a crucial role in identifying opioid use, enabling early intervention, and monitoring treatment progress.
| Country | The United Kingdom |
|---|---|
| Market Size (USD million) by End of Forecast Period (2033) | USD 32.0 million |
| CAGR % 2023 to End of Forecast (2033) | 4.3% |
The point-of-care opioid testing industry in the United Kingdom is expected to reach a market value of USD 32.0 million, expanding at a CAGR of 4.3% during the forecast period. Recent advancements in testing technologies have influenced the point-of-care opioid testing market in the UK.
These advancements include the development of more accurate, sensitive, and user-friendly testing devices. Point-of-care opioid testing technologies, such as immunoassays, oral fluid tests, and urine tests, have become more reliable and accessible, supporting wider adoption in various healthcare settings.
| Country | China |
|---|---|
| Market Size (USD million) by End of Forecast Period (2033) | USD 54.7 million |
| CAGR % 2023 to End of Forecast (2033) | 6.4% |
The point-of-care opioid testing industry in China is anticipated to reach a market size of USD 54.7 million, moving at a CAGR of 6.4% during the forecast period. The Chinese government has implemented initiatives and policies to combat substance abuse and improve public health outcomes.
These initiatives include strengthening regulations on opioid medications, establishing rehabilitation centers, and promoting the use of point-of-care opioid testing in healthcare facilities. Government support and policies have been crucial drivers for the adoption and growth of the point-of-care opioid testing market in China.
| Country | Japan |
|---|---|
| Market Size (USD million) by End of Forecast Period (2033) | USD 39.9 million |
| CAGR % 2023 to End of Forecast (2033) | 6.2% |
The point-of-care opioid testing industry in Japan is estimated to reach a market size of USD 39.9 million by 2033, thriving at a CAGR of 6.2%. Japan has seen increased research and development efforts in the field of point-of-care opioid testing. Academic institutions, research organizations, and healthcare companies are investing in the development of innovative testing methodologies, biomarkers, and data analysis algorithms.
This driver fosters continuous innovation, advancements in testing technologies, and the potential for personalized medicine approaches in opioid addiction management.
| Country | South Korea |
|---|---|
| Market Size (USD million) by End of Forecast Period (2033) | USD 45.4 million |
| CAGR % 2023 to End of Forecast (2033) | 6.0% |
The point-of-care opioid testing industry in South Korea is expected to reach a market size of USD 45.4 million, expanding at a CAGR of 6.0% during the forecast period. The South Korean government has implemented stricter regulations and monitoring measures for opioid medications.
These regulations aim to prevent misuse, addiction, and illegal distribution of opioids. The increased focus on monitoring drives the adoption of point-of-care opioid testing as a tool to ensure compliance with regulations and enhance patient safety.
Test strips are expected to dominate the point-of-care opioid testing industry with a CAGR of 4.7% from 2023 to 2033. Test strips are available for different sample types, including urine, saliva, and blood.
Urine is the most commonly used sample type for point-of-care opioid testing due to its ease of collection and high concentration of detectable substances. Saliva and blood samples may also be used in certain situations, such as in clinical laboratory settings or for specific testing requirements.
Multi-panel drug test kits are expected to dominate the point-of-care opioid testing industry with a CAGR of 5.2% from 2023 to 2033. Multi-panel kits allow for simultaneous testing of multiple drugs within a single device. Each drug panel on the test kit contains specific reagents or antibodies that react with the targeted drugs or their metabolites. When the sample is applied to the kit, it flows through the different panels, and if any of the targeted drugs are present, corresponding lines or color changes appear on the test result window.
Blood sample are expected to dominate the point-of-care opioid testing industry with a CAGR of 4.9% from 2023 to 2033. Blood samples provide a higher level of sensitivity and specificity compared to urine and saliva samples. The concentration of opioids and their metabolites in blood is generally higher and offers a more accurate representation of recent drug use. This makes blood testing particularly valuable in cases where precise quantification and detection of specific opioid compounds are required.
Forensic Laboratories is expected to dominate the point-of-care opioid testing industry with a CAGR of 5.4% from 2023 to 2033. Forensic laboratories play a crucial role in confirming preliminary point-of-care test results.
Point-of-care tests provide rapid screening but may have limitations in terms of sensitivity and specificity. Forensic laboratories perform confirmatory testing to validate the presence of opioids and determine the precise concentration or level of opioids in a sample. This information is essential for legal proceedings, workplace incidents, and clinical decision-making.
The point-of-care opioid testing market is fiercely competitive, with many companies fighting for market dominance. To stay ahead of the competition in such a circumstance, essential players must develop effective conjugates.
Key Strategies Used by the Participants
Product Development
Companies are investing in research & development to deliver product that improve efficiency, dependability, and cost-effectiveness. Product innovation allows businesses to differentiate themselves from their competition while also catering to the changing demands of their clients.
Strategic Alliances & Collaborations
Key industry leaders frequently develop strategic partnerships and collaborations with other companies in order to harness their strengths and increase their market reach. Companies might also gain access to new technology and markets through such agreements.
Expansion into Emerging Markets
The point-of-care opioid testing market is expanding rapidly in emerging regions such as China and India. Key firms are enhancing their distribution networks and developing local manufacturing facilities to increase their presence in these areas.
Acquisitions and mergers
Mergers and acquisitions are frequently used by key players in the point-of-care opioid testing industry to consolidate their market position, extend their product range, and gain access to new markets.
Check Free Sample Report & Save 40%!
Select your niche segments and personalize your insights for smart savings. Cut costs now!
Key Developments in the Point-of-care opioid testing Market:
The market is slated to attain USD 725.1 million by 2033.
The growth potential of the point-of-care opioid testing market is 4.9% CAGR through 2033.
Widespread abuse of opioid and increasing efficiencies in the point-of-care opioid testing are propelling the market growth.
Avon Healthcare, Triveni Traders & Diagnostic Private Limited, and AdvaCare Pharma USA are the top market players.
Product development and expansion into emerging markets are key strategies consolidating the key players’ position.
Explore In-vitro Diagnostics Devices Insights
View Reports
Point-of-Care Opioid Testing Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
